NF kappa B control A synthetic control for NFκB inhibitor (sc-3060)

NFκB control

NFκB control is rated 5.0 out of 5 by 1.
  • y_2019, m_4, d_23, h_2
  • bvseo_bulk, prod_bvrr, vn_bulk_2.0.12
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_3061, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 89ms
  • REVIEWS, PRODUCT
Synonym: AAVALLPAVLLALLAPVQRDGQKLMP
Application: A synthetic control for NFκB inhibitor (sc-3060)
Purity: ≥85% pure by HPLC
Molecular Weight: 2668.3
Molecular Formula: C123H215N33O30S
* Refer to Certificate of Analysis for lot specific data (including water content).
Submit a review for this product and receive 15 CruzCredits

NFκB control is a synthetic control for NFκB inhibitor. This is the inactive control for sc-3060.

Usage :
Following reconstitution, aliquot and freeze (-20°C).
Stock solutions are stable for up to 3 months at -20°C.
Avoid/freeze thaw cycles of solutions.
Physical State :
Solid
Sequence :
H-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Val-Gln-Arg-Asn-Gly-Gln-Lys-Leu-Met-Pro-OH
Storage :
Desiccate at -20° C
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

NF kappa B control  Product Citations

See how others have used NF kappa B control. Click on the entry to view the PubMed entry .

Citations 1 to 9 of 9 total

PMID: # 26867147  Prisco, AR. et al. 2016. Stem Cells. 34: 1922-33.

PMID: # 22968599  Inaba-Hasegawa, K. et al. 2013. Journal of neural transmission (Vienna, Austria : 1996). 120: 435-44.

PMID: # 21347708  2011. Mol. Cells. 31: 141-9.

PMID: # 19882112  Morais, C. et al. 2009. Angiogenesis. 12: -.

PMID: # 18374307  Condello, S. et al. 2008. Brain Res. 1207: 1-8.

PMID: # 18752574  2008. J. Thromb. Haemost. 6: 1858-67.

PMID: # 16998220  Morais, C. et al. 2006. Nephrol Dial Transplant. 21: 3377-3388.

PMID: # 16879219  2006. J. Thromb. Haemost. 4: 1763-73.

PMID: # 15983725  Nagy, I. et al. 2005. Journal of the Association for Research in Otolaryngology : JARO. 6: 260-8.

Citations 1 to 9 of 9 total
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 73ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of 5 by from Various publications cite the use of NF B Various publications cite the use of NF B control as a synthetic control for NF B inhibitor. -SCBT Publication Review
Date published: 2015-04-04
  • y_2019, m_4, d_23, h_2
  • bvseo_bulk, prod_bvrr, vn_bulk_2.0.12
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_3061, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 126ms
  • REVIEWS, PRODUCT

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.